RHUMBLINE ADVISERS - CORBUS PHARMACEUTICALS HLDGS ownership

CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 133 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q3 2020. The put-call ratio across all filers is 0.83 and the average weighting 0.1%.

Quarter-by-quarter ownership
RHUMBLINE ADVISERS ownership history of CORBUS PHARMACEUTICALS HLDGS
ValueSharesWeighting
Q1 2021$199,000
+54.3%
100,894
-2.0%
0.00%
Q4 2020$129,000
-19.4%
102,904
+15.7%
0.00%
Q3 2020$160,000
-81.3%
88,914
-12.7%
0.00%
-100.0%
Q2 2020$855,000
+98.8%
101,864
+24.3%
0.00%0.0%
Q1 2020$430,000
-2.5%
81,971
+1.4%
0.00%0.0%
Q4 2019$441,000
+15.4%
80,851
+3.1%
0.00%0.0%
Q3 2019$382,000
-30.0%
78,442
-0.5%
0.00%0.0%
Q2 2019$546,000
+16.4%
78,837
+16.7%
0.00%0.0%
Q1 2019$469,000
+24.1%
67,529
+4.4%
0.00%0.0%
Q4 2018$378,000
+18.5%
64,689
+52.9%
0.00%0.0%
Q3 2018$319,000
+38.7%
42,310
-7.0%
0.00%
Q2 2018$230,000
-11.5%
45,510
+6.8%
0.00%
-100.0%
Q1 2018$260,000
-1.1%
42,600
+15.0%
0.00%0.0%
Q4 2017$263,000
-19.3%
37,050
-18.8%
0.00%0.0%
Q3 2017$326,000
+15.2%
45,645
+1.5%
0.00%0.0%
Q2 2017$283,00044,9750.00%
Other shareholders
CORBUS PHARMACEUTICALS HLDGS shareholders Q3 2020
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 5,045,870$1,273,0000.73%
ETF MANAGERS GROUP, LLC 7,062,485$1,787,0000.05%
Ikarian Capital, LLC 862,527$217,0000.04%
IQ EQ FUND MANAGEMENT (IRELAND) Ltd 457,209$115,0000.02%
Platform Technology Partners 33,750$9,0000.01%
PINNACLE ASSOCIATES LTD 910,006$230,0000.01%
CJM Wealth Advisers, Ltd. 30,465$7,6830.01%
Mirae Asset Global Investments Co., Ltd. 4,029,171$1,016,0000.00%
Vident Investment Advisory, LLC 267,612$67,0000.00%
Aries Wealth Management 15,400$4,0000.00%
View complete list of CORBUS PHARMACEUTICALS HLDGS shareholders